Eosinophilic dermatosis after AstraZeneca COVID-19 vaccination
J Eur Acad Dermatol Venereol
.
2022 Mar;36(3):e171-e172.
doi: 10.1111/jdv.17806.
Epub 2021 Nov 20.
Authors
E Cinotti
1
,
J-L Perrot
2
,
F Bruzziches
1
,
L Tognetti
1
,
A Batsikosta
3
,
E Sorrentino
3
,
A V Marzano
4
5
,
P Rubegni
1
Affiliations
1
Dermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
2
Department of Dermatology, University Hospital of St-Etienne, Saint-Etienne, France.
3
Department of Human Pathology and Oncology, Pathological Anatomy Section, University of Siena, Siena, Italy.
4
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
5
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
PMID:
34753210
PMCID:
PMC8657533
DOI:
10.1111/jdv.17806
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Skin Diseases*
Vaccination
Substances
COVID-19 Vaccines